Cite
IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection.
MLA
Wu, Ruihong, et al. “IFNL4 Ss469415590 Polymorphism Contributes to Treatment Decisions in Patients with Chronic Hepatitis C Virus Genotype 1b, but Not 2a, Infection.” Infection, Genetics & Evolution, vol. 39, Apr. 2016, pp. 132–40. EBSCOhost, https://doi.org/10.1016/j.meegid.2016.01.020.
APA
Wu, R., Chi, X., Wang, X., Sun, H., Lv, J., Gao, X., Yu, G., Kong, F., Xu, H., Hua, R., Jiang, J., Sun, B., Zhong, J., Pan, Y., & Niu, J. (2016). IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection. Infection, Genetics & Evolution, 39, 132–140. https://doi.org/10.1016/j.meegid.2016.01.020
Chicago
Wu, Ruihong, Xiumei Chi, Xiaomei Wang, Haibo Sun, Juan Lv, Xiuzhu Gao, Ge Yu, et al. 2016. “IFNL4 Ss469415590 Polymorphism Contributes to Treatment Decisions in Patients with Chronic Hepatitis C Virus Genotype 1b, but Not 2a, Infection.” Infection, Genetics & Evolution 39 (April): 132–40. doi:10.1016/j.meegid.2016.01.020.